Research and Clinical Trials

Find A Clinical Trial

We are dedicated to offering you the latest and most innovative cancer care. Our doctors and research team will match you to the trial that is right for you. They will also discuss the risks and benefits of participating in a particular trial. We collaborate with Dayton Clinical Oncology Program as well as offering the following trials to bring research right here… close to home.

We are currently enrolling for the following trials:

Prostate - Advanced Hormone-Sensitive Prostate Cancer
Myovant - MVT-601-058 - A Multi-Center, Prospective, Observational Study of Patients Being Treated with ORGOVYX® NCT05467176

Multiple Cancers except for Breast and Thyroid
Tissue 32 Core HH - Harbinger Health Collection of Blood and Tissue Samples from Cancer and Non-Cancer Subjects for Validation of a Novel Blood-Based Multi-Cancer Screening Test NCT05435066

Coming Soon:

Immune Thrombocytopenia
CVAY736I12301: A phase III, randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to first-line corticosteroids in primary immune thrombocytopenia (VAYHIT1) NCT05653349

CVAY736Q12301: A phase 3 randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to eltrombopag in patients with primary immune thrombocytopenia (ITP) who had an insufficient response or relapsed after first line steroid treatment (VAYHIT2) NCT05653219

CVAY736O12301: A phase 3, randomized, double-blind, study to assess efficacy and safety of ianalumab (VAY736) versus placebo in warm autoimmune hemolytic anemia (wAIHA) patients who failed at least one line of treatment (VAYHIA) NCT05648968

For more information regarding these trials, call our Clinical Research Center at 937-771-2287 or email or go to and enter the NCT number.